Company registration number 11887215 (England and Wales)
JWB MEDICAL LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024
PAGES FOR FILING WITH REGISTRAR
JWB MEDICAL LTD
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 5
JWB MEDICAL LTD
BALANCE SHEET
AS AT
31 MARCH 2024
31 March 2024
- 1 -
2024
2023
Notes
£
£
£
£
Fixed assets
Tangible assets
4
1,661
1,726
Current assets
Debtors
5
12,134
5,134
Cash at bank and in hand
163,906
99,894
176,040
105,028
Creditors: amounts falling due within one year
6
(20,935)
(16,149)
Net current assets
155,105
88,879
Total assets less current liabilities
156,766
90,605
Provisions for liabilities
(415)
(432)
Net assets
156,351
90,173
Capital and reserves
Called up share capital
7
10
10
Profit and loss reserves
156,341
90,163
Total equity
156,351
90,173

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and signed by the director and authorised for issue on 14 November 2024
Mr JW Bradley
Director
Company registration number 11887215 (England and Wales)
JWB MEDICAL LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024
- 2 -
1
Accounting policies
Company information

JWB Medical Ltd is a private company limited by shares incorporated in England and Wales. The registered office is 4 Beacon Street, Low Fell, Gateshead, NE9 5XN.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for private medical services provided in the normal course of business.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computers
33% Straight line
1.4
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand and deposits held at call with banks.

1.5
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

JWB MEDICAL LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
1
Accounting policies
(Continued)
- 3 -
Basic financial liabilities

Basic financial liabilities, including creditors, are initially recognised at transaction price unless the arrangement constitutes a financing transaction.

1.6
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.7
Taxation

The tax expense represents the sum of the tax currently payable.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Total
1
1
3
Taxation
2024
2023
£
£
Current tax
UK corporation tax on profits for the current period
18,776
12,621
Deferred tax
Origination and reversal of timing differences
(17)
188
Total tax charge
18,759
12,809
JWB MEDICAL LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
- 4 -
4
Tangible fixed assets
Computers
£
Cost
At 1 April 2023
2,985
Additions
1,268
At 31 March 2024
4,253
Depreciation
At 1 April 2023
1,259
Depreciation charged in the year
1,333
At 31 March 2024
2,592
Carrying amount
At 31 March 2024
1,661
At 31 March 2023
1,726
5
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
11,773
5,068
Other debtors
361
66
12,134
5,134
6
Creditors: amounts falling due within one year
2024
2023
£
£
Corporation tax
18,775
12,621
Other creditors
2,160
3,528
20,935
16,149
7
Called up share capital
2024
2023
Ordinary share capital
£
£
Issued and fully paid
Ordinary shares of £1 each
10
10
JWB MEDICAL LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
- 5 -
8
Related party transactions
2024
2023
Amounts due to related parties
£
£
Director
-
1,368

The following amounts were outstanding at the reporting end date:

2024
2023
Amounts due from related parties
£
£
Director
292
-

There are no set terms as to repayment of this balance and no interest accruing thereon.

2024-03-312023-04-01false14 November 2024CCH SoftwareCCH Accounts Production 2024.100No description of principal activityMr JW Bradleyfalsefalse118872152023-04-012024-03-31118872152024-03-31118872152023-03-3111887215core:ComputerEquipment2024-03-3111887215core:ComputerEquipment2023-03-3111887215core:CurrentFinancialInstrumentscore:WithinOneYear2024-03-3111887215core:CurrentFinancialInstrumentscore:WithinOneYear2023-03-3111887215core:CurrentFinancialInstruments2024-03-3111887215core:CurrentFinancialInstruments2023-03-3111887215core:ShareCapital2024-03-3111887215core:ShareCapital2023-03-3111887215core:RetainedEarningsAccumulatedLosses2024-03-3111887215core:RetainedEarningsAccumulatedLosses2023-03-3111887215bus:Director12023-04-012024-03-3111887215core:ComputerEquipment2023-04-012024-03-31118872152022-04-012023-03-3111887215core:UKTax2023-04-012024-03-3111887215core:UKTax2022-04-012023-03-3111887215core:ComputerEquipment2023-03-3111887215core:WithinOneYear2024-03-3111887215core:WithinOneYear2023-03-3111887215bus:PrivateLimitedCompanyLtd2023-04-012024-03-3111887215bus:SmallCompaniesRegimeForAccounts2023-04-012024-03-3111887215bus:FRS1022023-04-012024-03-3111887215bus:AuditExemptWithAccountantsReport2023-04-012024-03-3111887215bus:FullAccounts2023-04-012024-03-31xbrli:purexbrli:sharesiso4217:GBP